Abiraterone acetate

Results: 15



#Item
1Microsoft WordDOCX

Microsoft WordDOCX

Add to Reading List

Source URL: securities.stanford.edu

Language: English - Date: 2016-08-03 18:48:38
2ANDROGENSINNSBRUCKSeptember 2016 Center for Chemistry and Biomedicine, CCB, Medical University Innsbruck Innrain 80-82, 6020 Innsbruck, Austria Lecture Hall EG

ANDROGENSINNSBRUCKSeptember 2016 Center for Chemistry and Biomedicine, CCB, Medical University Innsbruck Innrain 80-82, 6020 Innsbruck, Austria Lecture Hall EG

Add to Reading List

Source URL: www.androgens2016.net

Language: English - Date: 2016-08-02 11:08:54
3    January 14, 2016    The Honorable Sylvia Mary Mathews Burwell   Secretary 

    January 14, 2016    The Honorable Sylvia Mary Mathews Burwell   Secretary 

Add to Reading List

Source URL: keionline.org

Language: English - Date: 2016-01-14 11:38:01
4Zytiga, INN-abiraterone acetate

Zytiga, INN-abiraterone acetate

Add to Reading List

Source URL: www.ema.europa.eu

Language: Dutch - Date: 2015-04-30 09:43:37
    5HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA® (abiraterone acetate) Tablets F

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA® (abiraterone acetate) Tablets F

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2015-01-26 22:27:51
    6Benzoates / Carbamates / Abiraterone / Antiandrogens / Pyridines / Prostate cancer / Docetaxel / Cyclophosphamide / Cabazitaxel / Medicine / Chemistry / Organic chemistry

    6.1 ABIRATERONE ACETATE, tablet, 250 mg, Zytiga®, Janssen-Cilag Pty Ltd Purpose of Application Authority required listing for abiraterone for treatment of metastatic castrate-resistant prostate cancer (mCRPC) after tre

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2014-11-12 19:13:31
    7PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

    PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2014-11-10 21:39:36
    8PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

    PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2014-10-01 21:56:22
    9HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA® (abiraterone acetate) Tablets F

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA® (abiraterone acetate) Tablets F

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2012-12-14 15:40:09
    10USP Pending Monograph Draft 1—For Public Comment Abiraterone Acetate / 1  BRIEFING

    USP Pending Monograph Draft 1—For Public Comment Abiraterone Acetate / 1 BRIEFING

    Add to Reading List

    Source URL: www.usp.org

    Language: English - Date: 2013-09-26 17:16:07